AstraZeneca Other Non-Current Liabilities 2010-2024 | AZN

AstraZeneca other non-current liabilities for the quarter ending June 30, 2024 were $3.343B, a 12.56% decline year-over-year.

  • AstraZeneca other non-current liabilities for 2023 were $3.825B, a 28.24% decline from 2022.
  • AstraZeneca other non-current liabilities for 2022 were $5.33B, a 10.18% decline from 2021.
  • AstraZeneca other non-current liabilities for 2021 were $5.934B, a 11.03% decline from 2020.

AstraZeneca Other Non-Current Liabilities 2010-2024 | AZN

  • AstraZeneca other non-current liabilities for 2023 were $3.825B, a 28.24% decline from 2022.
  • AstraZeneca other non-current liabilities for 2022 were $5.33B, a 10.18% decline from 2021.
  • AstraZeneca other non-current liabilities for 2021 were $5.934B, a 11.03% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M